The Board granted a 60 percent rating for psoriasis from February 24, 2020 to April 1, 2025.
The deciding factor: The Veteran's psoriasis required near constant systemic therapy such as immunosuppressive drugs, warranting the assignment of a 60 percent rating under DC 7816.
- Claimed conditions
- Psoriasis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- May 21, 2025
- Citation
- A25045846
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted an earlier effective date of November 25, 2020, for the award of a 30 percent rating for dermatitis and psoriasis.
- Denied
The Board denied the Veteran's claims for a total disability rating based on individual unemployability (TDIU) and special monthly compensation under 38 U.S.C. § 1114(s).
- Denied
The Board denied a compensable rating for service-connected psoriasis and special monthly compensation prior to February 25, 2022.
- Granted
The Board granted restoration of the 30 percent disability evaluation for psoriasis and the 10 percent disability evaluation for right knee chondromalacia, effective July 1, 2024.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.